We Can Medicines Statistics
Total Valuation
TPEX:6929 has a market cap or net worth of TWD 899.55 million. The enterprise value is 1.73 billion.
Important Dates
The next estimated earnings date is Wednesday, March 10, 2027.
| Earnings Date | Mar 10, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6929 has 45.09 million shares outstanding. The number of shares has increased by 0.87% in one year.
| Current Share Class | 45.09M |
| Shares Outstanding | 45.09M |
| Shares Change (YoY) | +0.87% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | n/a |
| Float | 4.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.28 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | 2.91 |
| P/OCF Ratio | 2.64 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 6.83, with an EV/FCF ratio of 5.59.
| EV / Earnings | n/a |
| EV / Sales | 0.53 |
| EV / EBITDA | 6.83 |
| EV / EBIT | n/a |
| EV / FCF | 5.59 |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 1.07.
| Current Ratio | 1.51 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 4.17 |
| Debt / FCF | 3.41 |
| Interest Coverage | -2.59 |
Financial Efficiency
Return on equity (ROE) is -6.74% and return on invested capital (ROIC) is -3.35%.
| Return on Equity (ROE) | -6.74% |
| Return on Assets (ROA) | -2.41% |
| Return on Invested Capital (ROIC) | -3.35% |
| Return on Capital Employed (ROCE) | -3.35% |
| Weighted Average Cost of Capital (WACC) | 1.51% |
| Revenue Per Employee | 3.17M |
| Profits Per Employee | -68,226 |
| Employee Count | 1,020 |
| Asset Turnover | 1.12 |
| Inventory Turnover | 2.57 |
Taxes
In the past 12 months, TPEX:6929 has paid 18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.04% in the last 52 weeks. The beta is -0.56, so TPEX:6929's price volatility has been lower than the market average.
| Beta (5Y) | -0.56 |
| 52-Week Price Change | -38.04% |
| 50-Day Moving Average | 21.81 |
| 200-Day Moving Average | 26.13 |
| Relative Strength Index (RSI) | 38.06 |
| Average Volume (20 Days) | 6,644 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6929 had revenue of TWD 3.23 billion and -69.59 million in losses. Loss per share was -1.53.
| Revenue | 3.23B |
| Gross Profit | 1.06B |
| Operating Income | -62.10M |
| Pretax Income | -69.57M |
| Net Income | -69.59M |
| EBITDA | 1.53M |
| EBIT | -62.10M |
| Loss Per Share | -1.53 |
Full Income Statement Balance Sheet
The company has 226.12 million in cash and 1.05 billion in debt, with a net cash position of -827.40 million or -18.35 per share.
| Cash & Cash Equivalents | 226.12M |
| Total Debt | 1.05B |
| Net Cash | -827.40M |
| Net Cash Per Share | -18.35 |
| Equity (Book Value) | 988.91M |
| Book Value Per Share | 21.67 |
| Working Capital | 462.99M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 341.34 million and capital expenditures -32.34 million, giving a free cash flow of 308.99 million.
| Operating Cash Flow | 341.34M |
| Capital Expenditures | -32.34M |
| Depreciation & Amortization | 63.63M |
| Net Borrowing | -247.97M |
| Free Cash Flow | 308.99M |
| FCF Per Share | 6.85 |
Full Cash Flow Statement Margins
Gross margin is 32.79%, with operating and profit margins of -1.92% and -2.16%.
| Gross Margin | 32.79% |
| Operating Margin | -1.92% |
| Pretax Margin | -2.15% |
| Profit Margin | -2.16% |
| EBITDA Margin | 0.05% |
| EBIT Margin | -1.92% |
| FCF Margin | 9.57% |
Dividends & Yields
TPEX:6929 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.87% |
| Shareholder Yield | -0.87% |
| Earnings Yield | -7.69% |
| FCF Yield | 34.35% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6929 has an Altman Z-Score of 1.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.67 |
| Piotroski F-Score | 3 |